Position in OCUL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$101,606,813
+$13,968,350 QoQ
Shares Held
10,346,926
0.0% QoQ
Ownership
4.71%
of shares outstanding
% of Portfolio
3.08%
of 13F equity value
Holder Rank
#6
of 260 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OCUL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Venrock Adviser, LLC holds $3,294,790,938 across 31 Biotechnology names. OCUL ranks #6 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
8,493,321 | $1,127,318,496 | |
| 2 | ORKA |
Oruka Therapeutics, Inc.
|
4,148,428 | $394,805,892 | |
| 3 | ERAS |
Erasca, Inc.
|
17,891,812 | $327,777,995 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
2,985,448 | $265,048,073 | |
| 5 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
1,180,000 | $115,026,400 | |
| 6 | OCUL |
Ocular Therapeutix, Inc
This page
|
10,346,926 | $101,606,813 | |
| 7 | DMRA |
Damora Therapeutics, Inc.
|
3,603,595 | $93,729,505 | |
| 8 | SVRA |
Savara Inc
|
14,745,943 | $90,835,008 |
All Filings in OCUL
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $101,606,813 | 10,346,926 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $87,638,463 | 10,346,926 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $88,810,740 | 7,315,547 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $153,857,490 | 13,161,462 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $118,435,647 | 12,762,462 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $93,548,846 | 12,762,462 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $108,991,425 | 12,762,462 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $111,033,419 | 12,762,462 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $87,295,240 | 12,762,462 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $116,138,404 | 12,762,462 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $34,679,889 | 7,775,760 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||